Post-operative morbidity results in decreased long-term survival after resection for hilar cholangiocarcinoma

HPB

Volumn 13, Issue 2, 2011, Pages 139-147

  Chauhan, Aakash ^a   House, Michael G ^a   Pitt, Henry A ^a   Nakeeb, Attila ^a   Howard, Thomas J ^a   Zyromski, Nicholas J ^a   Schmidt, C Max ^a   Ball, Chad G ^a   Lillemoe, Keith D ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

cholangiocarcinoma; morbidity; mortality; outcomes; resection

Indexed keywords

ABDOMINAL ABSCESS; ADULT; AGED; ARTICLE; BACTEREMIA; BILE DUCT CARCINOMA; BILE LEAKAGE; BLEEDING; BLOOD TRANSFUSION; CANCER ADJUVANT THERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CHOLANGITIS; DEEP VEIN THROMBOSIS; DISEASE FREE SURVIVAL; FEMALE; HEART ARRHYTHMIA; HEPATOJEJUNOSTOMY; HILAR CHOLANGIOCARCINOMA; HUMAN; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; METASTASIS; MORBIDITY; MULTIPLE ORGAN FAILURE; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; PANCREATITIS; PERIOPERATIVE PERIOD; PLEURA EFFUSION; PNEUMONIA; PORTAL VEIN THROMBOSIS; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; SURGICAL MORTALITY; SURVIVAL TIME; UNIVARIATE ANALYSIS; URINARY TRACT INFECTION; WOUND DEHISCENCE; WOUND INFECTION;

EID: 78751668149     PISSN: 1365182X     EISSN: 14772574     Source Type: Journal    
DOI: 10.1111/j.1477-2574.2010.00262.x     Document Type: Article

References (48)

1. Khan SA, Thomas HC, Davidson BR, Taylor-Robinson SD,. (2005) Cholangiocarcinoma. Lancet 366: 1303-1314.
2. Patel T,. (2001) Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States. Hepatology 33: 1353-1357.
3. Nakeeb A, Pitt HA, Sohn TA, Coleman J, Abrams RA, Piantadosi S, et al. (1996) Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg 224: 463-475.
4. Nakeeb A, Tran KQ, Black MJ, Erickson BA, Ritch PS, Quebbeman EJ, et al. (2002) Improved survival in resected biliary malignancies. Surgery 132: 555-564.
5. Jarnagin WR, Fong Y, DeMatteo RP, Gonen M, Burke EC, Bodniewicz BJ, et al. (2001) Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg 234: 507-519.
6. Sano T, Shimada K, Sakamoto Y, Yamamoto J, Yamasaki S, Kosuge T., (2006) One hundred two consecutive hepatobiliary resections for perihilar cholangiocarcinoma with zero mortality. Ann Surg 244: 240-247.
7. Hemming AW, Reed AI, Fujita S, Foley DP, Howard RJ,. (2005) Surgical management of hilar cholangiocarcinoma. Ann Surg 241: 693-699. discussion 699-702.
8. Valle J, Wasan H, Palmer DH, Cunningham D, Anthoney A, Maraveyas A, et al. (2010) Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med 362: 1273-1281.
9. Ikeyama T, Nagino M, Oda K, Ebata T, Nishio H, Nimura Y,. (2007) Surgical approach to bismuth Type I and II hilar cholangiocarcinomas: audit of 54 consecutive cases. Ann Surg 246: 1052-1057.
10. Nishio H, Nagino M, Nimura Y,. (2005) Surgical management of hilar cholangiocarcinoma: the Nagoya experience. HPB (Oxford) 7: 259-262.
11. Baton O, Azoulay D, Adam DV, Castaing D,. (2007) Major hepatectomy for hilar cholangiocarcinoma type 3 and 4: prognostic factors and longterm outcomes. J Am Coll Surg 204: 250-260.
12. Endo I, House MG, Klimstra DS, Gonen M, D'Angelica M, DeMatteo RP, et al. (2008) Clinical significance of intraoperative bile duct margin assessment for hilar cholangiocarcinoma. Ann Surg Oncol 15: 2104-2112.
13. Otto G, Romaneehsen B, Hoppe-Lotichius M, Bittinger F,. (2004) Hilar cholangiocarcinoma: resectability and radicality after routine diagnostic imaging. J Hepatobiliary Pancreat Surg 11: 310-318.
14. Todoroki T, Kawamoto T, Koike N, Takahashi H, Yoshida S, Kashiwagi H, et al. (2000) Radical resection of hilar bile duct carcinoma and predictors of survival. Br J Surg 87: 306-313.
15. Hasegawa S, Ikai I, Fujii H, Hatano E, Shimahara Y., (2007) Surgical resection of hilar cholangiocarcinoma: analysis of survival and postoperative complications. World J Surg 31: 1256-1263.
16. Otani K, Chijiiwa K, Kai M, Ohuchida J, Nagano M, Tsuchiya K, et al. (2008) Outcome of surgical treatment of hilar cholangiocarcinoma. J Gastrointest Surg 12: 1033-1040.
17. Kennedy TJ, Yopp A, Qin Y, Zhao B, Guo P, Liu F, et al. (2009) Role of preoperative biliary drainage of liver remnant prior to extended liver resection for hilar cholangiocarcinoma. HPB (Oxford) 11: 445-451.
18. Garman KS, Pieper CF, Seo P, Cohen HJ,. (2003) Function in elderly cancer survivors depends on comorbidities. J Gerontol A Biol Sci Med Sci 58: M1119-M1124.
19. Ouellette JR, Small DG, Termuhlen PM,. (2004) Evaluation of Charlson-Age Comorbidity Index as predictor of morbidity and mortality in patients with colorectal carcinoma. J Gastrointest Surg 8: 1061-1067.
20. Seo PH, Pieper CF, Cohen HJ,. (2004) Effects of cancer history and comorbid conditions on mortality and healthcare use among older cancer survivors. Cancer 101: 2276-2284.
21. Chok KS, Ng KK, Poon RT, Lo CM, Fan ST., (2009) Impact of postoperative complications on long-term outcome of curative resection for hepatocellular carcinoma. Br J Surg 96: 81-87.
22. Farid SG, Aldouri A, Morris-Stiff G, Khan AZ, Toogood GJ, Lodge JP, et al. (2010) Correlation between postoperative infective complications and long-term outcomes after hepatic resection for colorectal liver metastasis. Ann Surg 251: 91-100.
23. Ito H, Are C, Gonen M, D'Angelica M, DeMatteo RP, Kemeny NE, et al. (2008) Effect of postoperative morbidity on long-term survival after hepatic resection for metastatic colorectal cancer. Ann Surg 247: 994-1002. (Pubitemid 351770420)
24. Katz SC, Shia J, Liau KH, Gonen M, Ruo L, Jarnagin WR, et al. (2009) Operative blood loss independently predicts recurrence and survival after resection of hepatocellular carcinoma. Ann Surg 249: 617-623.
25. Rizk NP, Bach PB, Schrag D, Bains MS, Turnbull AD, Karpeh M, et al. (2004) The impact of complications on outcomes after resection for esophageal and gastroesophageal junction carcinoma. J Am Coll Surg 198: 42-50.
26. Law WL, Choi HK, Lee YM, Ho JW,. (2007) The impact of postoperative complications on long-term outcomes following curative resection for colorectal cancer. Ann Surg Oncol 14: 2559-2566.
27. Schiesser M, Chen JW, Maddern GJ, Padbury RT,. (2008) Perioperative morbidity affects long-term survival in patients following liver resection for colorectal metastases. J Gastrointest Surg 12: 1054-1060.
28. Charlson ME, Pompei P, Ales KL, MacKenzie CR,. (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40: 373-383.
29. Greene F, Page D, Fleming I, Fritz A, Balch C, Haller D, et al. (2002) AJCC Cancer Staging Manual, 6th edn. New York, NY: Springer.
30. Dindo D, Demartines N, Clavien PA,. (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240: 205-213.
31. Dinant S, Gerhards MF, Busch OR, Obertop H, Guoma DJ, Van Gulik TM., (2005) The importance of complete excision of the caudate lobe in resection of hilar cholangiocarcinoma. HPB (Oxford) 7: 263-267.
32. Paik KY, Choi DW, Chung JC, Kang KT, Kim SB,. (2008) Improved survival following right trisectionectomy with caudate lobectomy without operative mortality: surgical treatment for hilar cholangiocarcinoma. J Gastrointest Surg 12: 1268-1274.
33. Hidalgo E, Asthana S, Nishio H, Wyatt J, Toogood GJ, Prasad KR, et al. (2008) Surgery for hilar cholangiocarcinoma: the Leeds experience. Eur J Surg Oncol 34: 787-794.
34. Jarnagin WR, Ruo L, Little SA, Klimstra D, D'Angelica M, DeMatteo RP, et al. (2003) Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma: implications for adjuvant therapeutic strategies. Cancer 98: 1689-1700.
35. Sasaki R, Takeda Y, Funato O, Nitta H, Kawamura H, Uesugi N, et al. (2007) Significance of ductal margin status in patients undergoing surgical resection for extrahepatic cholangiocarcinoma. World J Surg 31: 1788-1796.
36. Wakai T, Shirai Y, Moroda T, Yokoyama N, Hatakeyama K., (2005) Impact of ductal resection margin status on long-term survival in patients undergoing resection for extrahepatic cholangiocarcinoma. Cancer 103: 1210-1216.
37. Tralhao JG, Kayal S, Dagher I, Sanhueza M, Vons C, Franco D., (2007) Resection of hepatocellular carcinoma: the effect of surgical margin and blood transfusion on long-term survival. Analysis of 209 consecutive patients. Hepatogastroenterology 54: 1200-1206.
38. Sungurtekin H, Sungurtekin U, Balci C, Zencir M, Erdem E., (2004) The influence of nutritional status on complications after major intraabdominal surgery. J Am Coll Nutr 23: 227-232.
39. Birim O, Kappetein AP, Bogers AJ,. (2005) Charlson comorbidity index as a predictor of long-term outcome after surgery for nonsmall cell lung cancer. Eur J Cardiothorac Surg 28: 759-762.
40. Singh B, Bhaya M, Stern J, Roland JT, Zimbler M, Rosenfield RM, et al. (1997) Validation of the Charlson comorbidity index in patients with head and neck cancer: a multi-institutional study. Laryngoscope 107 (Part 1): 1469-1475.
41. Fernandez-Ruiz M, Guerra-Vales JM, Colina-Ruizdelgado F,. (2009) Comorbidity negatively influences prognosis in patients with extrahepatic cholangiocarcinoma. World J Gastroenterol 15: 5279-5286.
42. Kawasaki S, Imamura H, Kobayashi A, Noike T, Miwa S, Miyagawa S., (2003) Results of surgical resection for patients with hilar bile duct cancer: application of extended hepatectomy after biliary drainage and hemihepatic portal vein embolization. Ann Surg 238: 84-92.
43. Parikh AA, Abdalla EK, Vauthey JN,. (2005) Operative considerations in resection of hilar cholangiocarcinoma. HPB (Oxford) 7: 254-258.
44. Kressner U, Graf W, Mahteme H, Pahlman L, Glimelius B., (2002) Septic complications and prognosis after surgery for rectal cancer. Dis Colon Rectum 45: 316-321.
45. Balkwill F, Mantovani A,. (2001) Inflammation and cancer: back to Virchow? Lancet 357: 539-545.
46. Menetrier-Caux C, Montmain G, Dieu MC, Bain C, Favrot MC, Caux C, et al. (1998) Inhibition of the differentiation of dendritic cells from CD34(+) progenitors by tumor cells: role of interleukin-6 and macrophage colony-stimulating factor. Blood 92: 4778-4791.
47. Horn F, Henze C, Heidrich K,. (2000) Interleukin-6 signal transduction and lymphocyte function. Immunobiology 202: 151-167.
48. Hirano S, Kondo SKS, Tanaka E, Shichinohe T, Tsuchikawa T, Kato K, et al. (2009) Outcome of surgical treatment of hilar cholangiocarcinoma: a special reference to postoperative morbidity and mortality. J Hepatobiliary Pancreat Surg 17: 455-462.